Long-term outcomes with nivolumab in patients with previously treated advanced Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Thomas, M. [1 ,2 ]
Kohlhaeufl, M. [3 ]
Reck, M. [4 ]
Engel-Riedel, W. [5 ]
Kortsik, C. [6 ]
Bullinger, L. [7 ]
Schneider, C. -P. [8 ]
Felip, E. [9 ]
Brahmer, J. [10 ]
Vokes, E. [11 ]
Gettinger, S. [12 ]
Geese, W. [13 ]
Yoon, D. [13 ]
Healey, D. [13 ]
Li, A. [13 ]
Eberhardt, W. E. E. [14 ,15 ]
机构：
[1] Univ Klinikum Heidelberg, TLRC H, Internist Onkol Thoraxtumoren, Thoraxklin, Heidelberg, Germany
[2] German Ctr Lung Res DZL, Heidelberg, Germany
[3] Robert Bosch Krankenhaus, Stuttgart, Germany
[4] LungenClin Grosshansdorf, Grosshansdorf, Germany
[5] Kliniken Stadt Koln gGmbh, Krankenhaus Mehrheim, Cologne, Germany
[6] Katholisches Klinikum Mainz, Lungenzentrum, Mainz, Germany
[7] Univ Klinikum Ulm, Ulm, Germany
[8] Zent Klin Bad Berka Gmbh, Bad Berka, Germany
[9] Vall dHebron Univ Hosp, Barcelona, Spain
[10] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[11] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[12] Yale Canc Ctr, New Haven, CT USA
[13] Bristol Myers Squibb, Princeton, NJ USA
[14] Univ Duisburg Essen, Univ Hosp, Essen, Germany
[15] Univ Duisburg Essen, Ruhrlandklin, Essen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V510
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [1] Long-term survival outcomes with Nivolumab (Nivo) in patients with previously treated advanced non-small cell lung cancer (NSCLC): Impact of early disease control and response
    Wohlleber, M.
    Brahmer, J.
    Borghaei, H.
    Ramalingam, S. S.
    Horn, L.
    de Castro Carpeno, J.
    Pluzanski, A.
    Burgio, M. A.
    Garassino, M.
    Chow, L. Q. M.
    Gettinger, S.
    Crino, L.
    Planchard, D.
    Butts, C.
    Drilon, A.
    Wojcik-Tomaszewska, J.
    Otterson, G.
    Agrawal, S.
    Li, A.
    Penrod, J. R.
    Antonia, S. J.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 110 - 110
  • [2] Long-term survival outcomes with nivolumab (NIVO) in pts with previously treated advanced non-small cell lung cancer (NSCLC): Impact of early disease control and response
    Brahmer, Julie
    Borghaei, Hossein
    Ramalingam, Suresh S.
    Horn, Leora
    Holgado, Esther
    Pluzanski, Adam
    Burgio, Marco A.
    Garassino, Marina
    Chow, Laura Q.
    Gettinger, Scott
    Crino, Lucio
    Planchard, David
    Butts, Charles
    Drilon, Alexander
    Wojcik-Tomaszewska, Joanna
    Otterson, Gregory
    Hayreh, Vinny
    Li, Ang
    Penrod, John R.
    Antonia, Scott J.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [3] Long-term Survival Outcomes with Nivolumab (NIVO) in Pts with Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC): Impact of Early Disease Control and Response
    Brahmer, J.
    Horn, L.
    Hossein, B.
    Ramalingam, S.
    Pluzanski, A.
    Burgio, M. A.
    Garassino, M. C.
    Chow, L. Q. M.
    Gettinger, S.
    Crino, L.
    Planchard, D.
    Butts, C.
    Drilon, A.
    Wojcik-Tomaszewska, J.
    Otterson, G.
    Agrawal, S.
    Li, A.
    Penrod, J. R.
    Antonia, S. J.
    Bautista, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1152 - S1153
  • [4] Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Rogado, J.
    Pacheco-Barcia, V.
    Fenor De la Maza, M. D.
    Serra, J. M.
    Toquero, P.
    Vera, B.
    Obispo, B.
    Mondejar, R.
    Ballesteros, A.
    Donnay, O.
    Colomer, R.
    Sanchez-Torres, J. M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1915 - S1916
  • [5] Retrospective analysis of long-term survival factors in patients with advanced non-small cell lung cancer treated with nivolumab
    Murakami, Yusuke
    Tamiya, Akihiro
    Taniguchi, Yoshihiko
    Adachi, Yuichi
    Enomoto, Takatoshi
    Azuma, Koji
    Inagaki, Yuji
    Kouno, Shunichi
    Matsuda, Yoshinobu
    Okishio, Kyoichi
    Atagi, Shinji
    [J]. THORACIC CANCER, 2022, 13 (04) : 593 - 601
  • [6] Long-term survival in patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with nivolumab
    Topalian, Suzanne L.
    Hodi, F. Stephen
    Brahmer, Julie R.
    Gettinger, Scott N.
    Smith, David C.
    McDermott, David F.
    Powderly, John D.
    Sosman, Jeffrey A.
    Atkins, Michael B.
    Spigel, David R.
    Antonia, Scott J.
    Drilon, Alexander
    Bhore, Rafia
    Hosein, Fareeda
    Sznol, Mario
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [7] Nivolumab Experience in Patients with Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC) in Toledo, Spain
    Martinez Moreno, E.
    Irigoyen Medina, A.
    Martinez Barroso, K.
    Borregon Rivilla, M.
    Alvarez Cabellos, R.
    Cardenas, J. D.
    Andrade Santiago, J.
    Burgueno Lorenzo, I.
    Trujillo Alba, B.
    Chacon Lopez-Muniz, J. I.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2430 - S2430
  • [8] Feasibility Study of Nivolumab and Docetaxel in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
    Shimokawa, T.
    Nakamura, Y.
    Iwasawa, S.
    Miyazaki, K.
    Yamanaka, T.
    Takiguchi, Y.
    Okamoto, H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2431 - S2431
  • [9] Feasibility study of nivolumab and docetaxel in previously treated patients with advanced non-small cell lung cancer
    Miyazaki, Kazuhito
    Iwasawa, Shunichiro
    Nakamura, Yukiko
    Shimokawa, Tsuneo
    Yamanaka, Takeharu
    Takiguchi, Yuichi
    Okamoto, Hiroaki
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC)
    Crino, L.
    Ahn, M-J.
    Han, J-Y.
    Liu, X.
    Ou, S-H. I.
    Shaw, A. T.
    Yang, P-C.
    Shi, Y-K.
    Lanzalone, S.
    Polli, A.
    Wilner, K. D.
    Kim, D-W.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
12345